Russell Investments Group, Ltd. Acumen Pharmaceuticals, Inc. Transaction History
Russell Investments Group, Ltd.
- $70.2 Billion
- Q1 2025
A detailed history of Russell Investments Group, Ltd. transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 278 shares of ABOS stock, worth $333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
278
Previous 1,237
77.53%
Holding current value
$333
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ABOS
# of Institutions
83Shares Held
38.5MCall Options Held
39.1KPut Options Held
53.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$17.9 Million0.34% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.1 Million1.6% of portfolio
-
Franklin Resources Inc San Mateo, CA3.14MShares$3.77 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.32 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $48.6M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...